Nordlys

Overview

Nordlys is Candela (Syneron)'s entry in the vascular/pigment category, built on Narrowband IPL (SWT) + Frax 1550 Fractional + Nd:YAG 1064nm. The platform treats face, body vascular and pigmented lesions, hair removal, acne, with 15-30 minutes and a recommended course of 3-6 sessions depending on indication. FDA cleared in 2017, it lists in the $85,000-$135,000 range for new units and $35,000-$65,000 on the secondary market.

Multi-application platform with Selective Waveband Technology (SWT) narrowband IPL, Frax 1550 non-ablative fractional handpiece, and Nd:YAG in one system. Targets dermatology practices wanting a single device for vascular, pigmented, hair removal, and resurfacing work. The mechanism is what separates Nordlys from competitors in the same category. Where it fits in your practice depends on patient demographics, treatment volume, and whether you need a flagship platform or a value-tier alternative.

Nordlys is manufactured by Candela (Syneron) (Wayland, MA, founded 1970). The device benefits from Candela (Syneron)'s long manufacturer history and presence across 100+ countries. Service support, training availability, and parts access vary by region. Practices considering this device should validate dealer presence and technical support coverage in their area before signing a contract.

Pros & Cons

Clinical Evidence

25+ published studies across indications. Strong data for rosacea, photodamage, and hair removal. The published evidence base for Nordlys reflects how long the platform has been in market and how much the manufacturer has invested in clinical research. Devices with FDA clearance dates before 2018 typically have stronger peer-reviewed datasets than newer entrants. For physicians evaluating this device, the questions worth asking are whether the studies used blinded evaluators, what the sample sizes were, and whether the research was independent or manufacturer-funded.

Compare Nordlys's evidence base against the category benchmark. In Nordlys's category, the strongest evidence typically comes from devices that have been on the market for at least five years and have multiple randomized controlled trials with independent funding. Marketing claims from any manufacturer should be cross-checked against PubMed-indexed publications rather than conference posters or white papers. Conference presentations are not equivalent to peer review.

For practices that require strong clinical evidence (academic dermatology, plastic surgery groups with research interests, multi-physician practices that need to defend purchase decisions internally), the evidence profile should be a top-three decision factor. For high-volume cash-pay practices where patient demand drives device selection, brand recognition often matters more than the underlying evidence base. Both approaches are defensible, but they lead to different device selections.

ROI Analysis

Practice ROI for Nordlys depends on three variables: capital cost, per-session revenue, and treatment volume. At a new unit price of $85,000-$135,000, financed over five years at typical equipment rates, the monthly payment runs roughly 2-2.5% of total cost. Per-session revenue at $200-$900 means the device needs to fill enough treatment slots monthly to cover the payment, consumables ($1,500-$4,000), maintenance ($5,000-$9,000), and operator labor.

For a practice doing 2-3 treatments per day at the midpoint of the per-session range, Nordlys typically reaches break-even at 12-18 months for the lower end of the new pricing range, or 18-30 months at the high end. Used and refurbished units in the $35,000-$65,000 range can cut payback periods in half. The biggest practice mistake is over-projecting treatment volume. Physicians who run their numbers on 4-6 daily treatments rarely hit those targets in year one.

The realistic question is not whether Nordlys can pay back. Most devices in this price range do, eventually. The question is whether your practice can fill the schedule. Practices with existing patient flow in Dermatology, Plastic Surgery have the easiest path. Practices building demand from scratch should plan for 6-12 months of marketing investment before the device pays for itself.

Best For

Dermatology practices that want a single workhorse platform covering vascular, pigmented, hair removal, and light resurfacing at a moderate capital cost. Starter platforms for med spas entering aesthetic lasers. The fit is strongest for practices that match the device's positioning on price, clinical evidence requirements, and patient throughput expectations. Practices with mismatched economics often regret these purchases within 18 months.

Beyond practice type, Nordlys fits best when the patient base aligns with the device's strengths. For vascular/pigment platforms, this usually means matching device capability to patient demographics, skin type range, and willingness to pay per-session pricing. Practices in markets where patients price-shop heavily need to factor that into device selection. Practices in concierge or luxury markets can charge premium pricing that justifies premium platforms.

Buying Guide

New Nordlys units sell for $85,000-$135,000 from Candela (Syneron) or authorized dealers. Refurbished and used units sell for $35,000-$65,000 on the secondary market. The decision between new and used comes down to warranty coverage, software version, included applicators, and consumable allowances. New units typically include a 12-24 month warranty, current software, all applicators, and a starter consumable package. Used units usually carry no warranty, may have outdated software, and require separate consumable purchases.

What to negotiate: applicator quantity (always ask for additional applicators thrown in), consumable starter packs, training and certification fees, extended warranty coverage, marketing materials, and clinical training for additional providers. Candela (Syneron) sales reps typically have 10-15% list price flexibility and far more on bundled deals. End-of-quarter and end-of-year are the strongest negotiation windows. Trade-in programs for older devices can reduce net cost by another 10-20%.

What to watch for: software lock-out fees on used units (some manufacturers disable software on resold devices), per-pulse or per-treatment licensing fees that show up after purchase, consumable price increases over the device life, and service contract terms. Always require a written quote that breaks out hardware, applicators, training, first-year service, and consumables separately. Bundled quotes hide the line items where margins live.

Alternatives and Comparisons

The main alternatives to Nordlys in this category are listed below. Click into any comparison for a full side-by-side breakdown.